Proteolysis-targeting chimeras (PROTACs) and molecular glue degraders (MGDs) are the most maturely created TPD approaches. On this evaluation, we target both of those preclinical experiments and medical trials to deliver a comprehensive summary of the security and clinical efficiency of PROTACs and MGDs in hematologic malignancies over the past 20 https://johng296xcf0.therainblog.com/profile